KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 102 filers reported holding KALA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 1.39 and the average weighting 0.3%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $77,000 | -17.2% | 55,700 | -27.8% | 0.00% | – |
Q4 2021 | $93,000 | -58.7% | 77,100 | -10.2% | 0.00% | – |
Q3 2021 | $225,000 | -50.5% | 85,900 | 0.0% | 0.00% | – |
Q2 2021 | $455,000 | +59.1% | 85,900 | +102.1% | 0.00% | – |
Q1 2021 | $286,000 | -29.2% | 42,500 | -28.7% | 0.00% | – |
Q4 2020 | $404,000 | -8.2% | 59,600 | +1.5% | 0.00% | – |
Q3 2020 | $440,000 | -28.7% | 58,700 | 0.0% | 0.00% | – |
Q2 2020 | $617,000 | +61.9% | 58,700 | +35.3% | 0.00% | – |
Q1 2020 | $381,000 | +556.9% | 43,400 | +176.4% | 0.00% | – |
Q4 2019 | $58,000 | -3.3% | 15,700 | 0.0% | 0.00% | – |
Q3 2019 | $60,000 | -40.0% | 15,700 | 0.0% | 0.00% | – |
Q2 2019 | $100,000 | -78.1% | 15,700 | -21.5% | 0.00% | – |
Q3 2017 | $457,000 | – | 20,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CAXTON CORP | 771,790 | $5,788,000 | 5.46% |
RA Capital Management | 10,874,613 | $81,560,000 | 1.49% |
Mesirow Financial Investment Management, Inc. | 36,445 | $273,000 | 1.17% |
Samsara BioCapital, LLC | 451,162 | $3,384,000 | 0.94% |
Parkman Healthcare Partners LLC | 310,053 | $2,325,000 | 0.62% |
Orbimed Advisors | 5,465,030 | $40,988,000 | 0.52% |
Eventide Asset Management | 3,450,000 | $25,875,000 | 0.51% |
Vivo Capital, LLC | 786,883 | $5,902,000 | 0.34% |
Ikarian Capital, LLC | 451,531 | $3,387,000 | 0.24% |
Matisse Capital | 50,300 | $377,000 | 0.15% |